Cargando…
Leveraging circulating microbiome signatures to predict tumor immune microenvironment and prognosis of patients with non-small cell lung cancer
BACKGROUND: Accumulating evidence supports the significant role of human microbiome in development and therapeutic response of tumors. Circulating microbial DNA is non-invasive and could show a general view of the microbiome of host, making it a promising biomarker for cancers. However, whether circ...
Autores principales: | Zhou, Xiaohan, You, Liting, Xin, Zhaodan, Su, Huiting, Zhou, Juan, Ma, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636862/ https://www.ncbi.nlm.nih.gov/pubmed/37950236 http://dx.doi.org/10.1186/s12967-023-04582-w |
Ejemplares similares
-
Novel directions of precision oncology: circulating microbial DNA emerging in cancer-microbiome areas
por: You, Liting, et al.
Publicado: (2022) -
Leveraging Tumor Microenvironment Infiltration in Pancreatic Cancer to Identify Gene Signatures Related to Prognosis and Immunotherapy Response
por: Yang, Jiabin, et al.
Publicado: (2023) -
The ferroptosis signature predicts the prognosis and immune microenvironment of nasopharyngeal carcinoma
por: Zhou, Ji, et al.
Publicado: (2023) -
An Immune Panel Signature Predicts Prognosis of Lung Adenocarcinoma Patients and Correlates With Immune Microenvironment
por: Zhou, Yuan, et al.
Publicado: (2021) -
Construction of an Immune-Related lncRNA Signature That Predicts Prognosis and Immune Microenvironment in Osteosarcoma Patients
por: He, Yi, et al.
Publicado: (2022)